AI Market Cap Pro
← Back to Scanner Pricing
📅 Next earnings: October 29, 2026

Illumina, Inc. (ILMN) — Pre-Earnings Stock Analysis

Healthcare, Diagnostics & Research

$274.09
Current Price
$41.4B
Market Cap
50.9
Trailing P/E
$234
Analyst Target
20
Analysts
Buy
Rating

🔥 Get ILMN Targets Before Earnings

Pre-earnings entry zone, analyst PE target, 3-day and 5-day implied move, and stop loss — all unlocked with a $5/month subscription.

Unlock Full Analysis →

About Illumina, Inc. (ILMN)

Illumina, Inc. trades on NASDAQ under the ticker ILMN. The company operates in the Healthcare sector — specifically Diagnostics & Research.

Current analyst consensus rating: Buy with a $234 price target based on 20 analyst opinions.

EPS (trailing): $5.39  |  Market Cap: $41.4B

Healthcare Diagnostics & Research

Pre-Earnings Trading Strategy for ILMN

Trading stocks before earnings requires understanding three key variables: the implied move (what the options market expects), the historical beat rate for the sector, and the current momentum leading into the report.

For ILMN, the next earnings report is scheduled for October 29, 2026.

The implied move is calculated using at-the-money straddles — if the straddle is priced at X%, the market is pricing in approximately a ±X% move in either direction around the earnings release.

How AI Market Cap Finds Pre-Earnings Setups

Our pre-earnings momentum scanner scores ILMN across five factors to identify high-conviction setups:

The Pro subscription shows the full target range, stop loss, and implied move for ILMN and all 20+ stocks in the current earnings window.